# AML Biotech Partners

AML Biotech Partners is an Asset Manager based in Pasadena, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Pasadena, United States
- **Region:** North America
- **Address:** Pasadena, CA, United States
- **Assets under management:** Undisclosed
- **Website:** amlbiotech.com

## Regulatory record

- **Reports private funds:** No

## About

AML Biotech Partners is an investment firm focused on early-stage biotechnology and life sciences companies. The firm operates from its primary location in Pasadena, California, with a presence in Summit, New Jersey, Chicago, Illinois, and San Francisco, California. This multi-hub structure positions AML near several of the country's most productive academic and medical research ecosystems. AML Biotech Partners targets therapeutics and platform-technology companies at the earliest stages of development, often engaging with scientific founders around university spinouts. The firm participates in seed and Series A financings across modalities including small molecules, biologics, and enabling life-science tools. Its strategy relies on proximity to dense innovation clusters — the Caltech and greater Los Angeles biomedical community from Pasadena, the pharmaceutical corridor in New Jersey, the Midwest research hospitals from Chicago, and the Bay Area venture-science nexus from San Francisco. Operational details on team size and total committed capital are not publicly disclosed. The absence of a public website with detailed team or portfolio information limits what outside allocators can independently verify about the firm's current deployment pace or fund structure. AML does not maintain a public-facing LinkedIn company page or widely circulated investor letters available to the institutional market. Structurally, AML Biotech Partners represents a strategy built on regional scientific access rather than centralized asset-gathering.

## Sectors

- Biotech
- Healthcare Services

## Offices

- Summit, NJ
- Chicago, IL
- San Francisco, CA

## Questions

### Who runs investment decisions at AML Biotech Partners?

AML Biotech Partners does not publicly disclose its leadership team or investment committee structure. Without a public website detailing its principals, the identities of the firm's managing partners and decision-makers are not verifiable through standard external sources.

### What is AML Biotech Partners' known posture on co-investments?

The firm does not publicly state its co-investment policies. Given its participation in early-stage biotech syndicates, third-party allocators interested in co-investment opportunities should engage directly with the firm, as no written co-investment framework is available in the public domain.

## Related profiles

- [AMF Capital Management](https://altss.com/profile/amf-capital-management)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/aml-biotech-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology